Exposure to TNF inhibitors increases psoriasis risk in children with IBD, JIA

Children with inflammatory bowel disease, juvenile idiopathic arthritis and chronic noninfectious osteomyelitis had an increased rate of psoriasis, and those exposed to tumor necrosis factor inhibitor therapy exhibited the highest risk, according to research presented at the American College of Rheumatology/Association of Rheumatology Professionals annual meeting.“TNF-alpha inhibiting therapies are a cornerstone of treatment for inflammatory conditions such as IBD, JIA and chronic noninfectious osteomyelitis but have been increasingly implicated in the development of psoriasis,”Read More

Share on facebook
Share on twitter
Share on linkedin